Cataract Surgery Planning in Amblyopic Patients - Which eye first? Awareness of the Potential for Post-operative Diplopia amongst Consultant Ophthalmic Surgeons in Wales.
CONCLUSION: These results indicate that awareness of post-cataract surgery diplopia, and in particular fixation switch diplopia, is not widespread amongst consultant ophthalmic surgeons in Wales. PMID: 24082284 [PubMed - as supplied by publisher] (Source: The Ulster Medical Journal)
Source: The Ulster Medical Journal - May 1, 2013 Category: Journals (General) Authors: Samuel Williams G, Radwan M, Menon J Tags: Ulster Med J Source Type: research

Availability of anti-VEGF agents for the management of advanced diabetic retinopathy in the NHS
The anti-vascular endothelial growth factor (anti-VEGF) drug Bevacizumab (Avastin Genentech Inc. (Roche Group), San Francisco, California, USA) has been in circulation for several years within the ophthalmic community. Numerous studies have reported clinical outcomes of Bevacizumab in the context of proliferative diabetic retinopathy (PDR)1–4 and neovascular glaucoma. These, including a comprehensive review5 and a meta-analysis,6 have all reported favourable clinical outcomes. Studies therefore confirm that Bevacizumab reduces the risk of haemorrhage, reduces the need for endodiathermy, facilitates surgery and reduce...
Source: British Journal of Ophthalmology - January 18, 2013 Category: Opthalmology Authors: Malik, A., Zambarakji, H. Tags: Letters Source Type: research

The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary
The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary Eye advance online publication, January 11 2013. doi:10.1038/eye.2012.287 Authors: F Ghanchithe Diabetic Retinopathy Guidelines Working Group (Source: Eye)
Source: Eye - January 11, 2013 Category: Opthalmology Authors: F Ghanchi Source Type: research